GRANDFIELD & DODD, LLC Neurocrine Biosciences, Inc. Transaction History

GRANDFIELD & DODD, LLC portfolio value:

$1.52M
portfolio value

GRANDFIELD & DODD, LLC quarter portfolio value change:

+8.96%
quarter

Neurocrine Biosciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +2.53% 352 shares 160K $106.21 14.27K
Q2 2022 share Increase +0.94% 130 shares 70K $97.48 13.92K
Q1 2022 share Increase +4.28% 566 shares 160K $93.75 13.79K
Q4 2021 share Increase +11.12% 1.32K shares -10K $84.63 13.23K
Q3 2021 share Increase +1.40% 164 shares 0 $95.91 11.90K
Q2 2021 share Increase +1.64% 190 shares 20K $97.32 11.74K
Q1 2021 share Increase +1.53% 174 shares 30K $97.25 11.55K
Q4 2020 share Increase +2.36% 262 shares 20K $95.85 11.37K
Q3 2020 share Increase +0.73% 81 shares -280K $96.16 11.11K
Q2 2020 share Increase +5.75% 600 shares 447K $122 11.03K
Q1 2020 share Increase +4.30% 430 shares -173K $86.55 10.43K
Q4 2019 share Increase +5.70% 540 shares 223K $107.49 10.00K
Q3 2019 share Increase +9.93% 855 shares 126K $90.11 9.46K
Q2 2019 share Increase +9.26% 730 shares 33K $84.43 8.61K
Q1 2019 share Increase +0.78% 61 shares 136K $88.1 7.88K
Q4 2018 share Increase +0.84% 65 shares -395K $71.41 7.82K
Q3 2018 share Increase +0.91% 70 shares 198K $122.95 7.75K
Q2 2018 share Increase +0.52% 40 shares 121K $98.24 7.68K
Q1 2018 share Decrease -3.41% -270 shares 20K $82.93 7.64K
Q4 2017 share Increase +4.01% 305 shares 148K $77.59 7.91K
Q3 2017 share Increase +24.14% 1.48K shares 184K $61.28 7.61K
Q2 2017 share Increase +15.23% 810 shares 52K $46 6.13K
Q1 2017 share Increase 0.00% 5.32K shares 230K $43.3 5.32K